NATIXIS ADVISORS, L.P. – AbbVie Inc. Transaction History
NATIXIS ADVISORS, L.P. portfolio value:
$89.19M
portfolio value
NATIXIS ADVISORS, L.P. quarter portfolio value change:
-12.37%
quarter
AbbVie Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Increase | +15.33% | 88.31K shares | 933K | $134.21 | 664.56K |
Q2 2022 | share | Decrease | -4.23% | -25.47K shares | -9.28M | $153.16 | 576.24K |
Q1 2022 | share | Increase | +14.15% | 74.57K shares | 26.16M | $162.11 | 601.72K |
Q4 2021 | share | Increase | +13.35% | 62.09K shares | 21.21M | $135.93 | 527.14K |
Q3 2021 | share | Decrease | -1.42% | -6.68K shares | -2.97M | $106.6 | 465.05K |
Q2 2021 | share | Increase | +11.23% | 47.60K shares | 7.23M | $110.09 | 471.74K |
Q1 2021 | share | Increase | +11.09% | 42.34K shares | 4.99M | $104.49 | 424.13K |
Q4 2020 | share | Decrease | -15.96% | -72.52K shares | 1.11M | $102.27 | 381.78K |
Q3 2020 | share | Decrease | -26.51% | -163.89K shares | -20.90M | $82.47 | 454.31K |
Q2 2020 | share | Increase | +9.76% | 54.98K shares | 17.78M | $91.35 | 618.20K |
Q1 2020 | share | Decrease | -19.84% | -139.44K shares | -19.30M | $69.88 | 563.22K |
Q4 2019 | share | Increase | +4.52% | 30.40K shares | 11.31M | $80.14 | 702.66K |
Q3 2019 | share | Increase | +17.25% | 98.89K shares | 9.20M | $67.55 | 672.26K |
Q2 2019 | share | Increase | +33.13% | 142.67K shares | 6.98M | $63.9 | 573.37K |
Q1 2019 | share | Increase | +1.04% | 4.42K shares | -4.58M | $69.89 | 430.69K |
Q4 2018 | share | Increase | +91.13% | 203.24K shares | 18.20M | $78.96 | 426.26K |
Q3 2018 | share | Decrease | -6.96% | -16.68K shares | -1.11M | $80.16 | 223.02K |
Q2 2018 | share | Decrease | -0.12% | -282 shares | -507K | $77.74 | 239.70K |
Q1 2018 | share | Increase | 0.00% | 239.98K shares | 22.71M | $78.6 | 239.98K |
Q4 2017 | share | Decrease | -10.70% | -28.27K shares | -660K | $79.74 | 236.01K |
Q3 2017 | share | Increase | +0.58% | 1.52K shares | 4.43M | $72.76 | 264.29K |
Q2 2017 | share | Decrease | -16.63% | -52.43K shares | -1.48M | $58.85 | 262.77K |
Q1 2017 | share | Decrease | -1.78% | -5.72K shares | 443K | $52.36 | 315.20K |
Q4 2016 | share | Increase | +0.02% | 76 shares | -140K | $49.8 | 320.93K |
Q3 2016 | share | Increase | +4.60% | 14.10K shares | 1.24M | $49.69 | 320.85K |
Q2 2016 | share | Decrease | -7.06% | -23.29K shares | 139K | $48.35 | 306.74K |
Q1 2016 | share | Increase | +123.56% | 182.41K shares | 10.10M | $44.19 | 330.04K |